期刊文献+

老年慢性心力衰竭患者血清suPAR、PAI-1表达与预后的相关性研究 被引量:5

Correlation between expressions of serum suPAR and PAI-1 and prognosis in elderly patients with chronic heart failure
下载PDF
导出
摘要 目的通过检测老年慢性心力衰竭(心衰)患者血清中可溶性尿激酶型纤溶酶原激活物受体(suPAR)、纤溶酶原激活物抑制因子(PAI-1)表达,解析其与老年慢性心衰病情及预后的关系。方法选取2018年1月至2020年1月于辽宁中医药大学附属医院确诊的老年慢性心衰患者120例为心衰组,同时根据NYHA分级分为Ⅱ、Ⅲ、Ⅳ级三个亚组,另选取同期健康体检者70例为对照组。采用酶联免疫吸附实验(ELISA)测定并比较各组老年慢性心衰患者及对照组血清suPAR、PAI-1、N末端脑钠肽前体(NT-proBNP)表达水平。根据患者1年内主要不良心血管事件(MACE)发生情况分为预后良好组和预后不良组,比较两组间血清suPAR和PAI-1水平。受试者工作特征曲线(ROC)测定血清suPAR、PAI-1对患者不良预后的诊断价值,多因素Logistic回归分析影响老年慢性心衰患者MACE发生的危险因素。结果与对照组相比,心衰组患者NT-proBNP、左室射血分数(LVEF)、左心室舒张末内径(LVEDD)、血清suPAR、PAI-1水平显著升高(P<0.05);随着NYHA分级的升高,老年慢性心衰患者血清中suPAR、PAI-1表达水平逐渐升高(P<0.05);与预后良好组相比,预后不良组老年慢性心衰患者NTproBNP、LVEF、LVEDD、血清suPAR、PAI-1表达水平显著升高(P<0.05)。随访结果显示,发生预后不良老年慢性心衰患者48例,ROC曲线结果显示,血清suPAR、PAI-1表达水平诊断老年慢性心衰患者不良预后曲线下面积(AUC)为0.836(95%CI:0.758~0.914)、0.757(95%CI:0.662~0.853);多因素Logistic回归分析显示NT-proBNP、LVEF、LVEDD、血清suPAR、PAI-1水平为患者发生预后不良的危险因素(P<0.05)。结论老年慢性心力衰竭患者血清中suPAR、PAI-1水平随着病情严重程度增加而增加,是老年慢性心衰患者不良预后的危险因素,具有一定临床诊断价值。 Objective To analyze the relationship among serum soluble urokinase plasminogen activator receptor(suPAR)and plasminogen activator inhibitors-1(PAI-1),conditions and prognosis in elderly patients with chronic heart failure(CHF)through detecting expressions of suPAR and PAI-1.Methods CHF patients(n=120)were chosen into heart failure group(HF group)from the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine from Jan.2018 to Jan.2020,and at the same time,HF group was divided,according to NYHA classification,into gradeⅡsubgroup,gradeⅢsubgroup and gradeⅣsubgroup.Meanwhile the controls with healthy examination(n=70)were chosen into control group.The expressions of suPAR,PAI-1 and N-terminal probrain natriuretic peptide(NT-proBNP)were detected by using ELISA in all groups.The patients were divided,according to incidence of major adverse cardiovascular events(MACE)within 1 y,into good prognosis group and poor prognosis group,and levels of serum suPAR and PAI-1 were compared between 2 groups.The diagnostic value of suPAR and PAI-1 to poor prognosis was detected by using ROC curve,and risk factors of MACE were analyzed by using multi-factor Logistic regression analysis in elderly CHF patients.Results The levels of NT-proBNP,left ventricular ejection fraction(LVEF)and left ventricular end-diastolic inner diameter(LVEDD),and expressions of serum suPAR and PAI-1 increased significantly in HF group compared with control group(P<0.05).As the increases of NYHA grades,the expressions of serum suPAR and PAI-1 increased(P<0.05).The levels of NTproBNP,LVEF and LVEDD and expressions of serum suPAR and PAI-1 increased significantly in poor prognosis group compared with good prognosis group(P<0.05).The results of follow-up showed that there were 48 elderly CHF patients with poor prognosis.The results of ROC curve analysis showed that the area under the curve(AUC)of suPAR was 0.836(95%CI:0.758~0.914)and AUC of PAI-1 was 0.757(95%CI:0.662~0.853)in diagnosis of poor prognosis in elderly CHF patients.The multi-factor Logistic regression analysis showed that the levels of NTpro BNP,LVEF and LVEDD and expressions of serum suPAR and PAI-1 were risk factors of poor prognosis(P<0.05).Conclusion The expressions of serum suPAR and PAI-1 will increase as the severity of CHF condition increases,which are risk factors of poor prognosis with some clinical diagnostic value in elderly CHF patients.
作者 赵茜 董晓茜 姜冲 丛敬 陈文娜 Zhao Qian;Dong Xiaoxi;Jiang Chong;Cong Jing;Chen Wenna(Department of Cardiology,Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Shenyang 110033,China;不详)
出处 《中国循证心血管医学杂志》 2022年第8期936-939,共4页 Chinese Journal of Evidence-Based Cardiovascular Medicine
基金 国家自然科学基金青年科学项目(81300229)。
关键词 慢性心力衰竭 可溶性尿激酶型纤溶酶原激活物受体 纤溶酶原激活物抑制因子 预后 Chronic heart failure Soluble urokinase plasminogen activator receptor Plasminogen activator inhibitors Prognosis
  • 相关文献

参考文献7

二级参考文献78

  • 1托伐普坦临床研究协作组,张健,朱文玲.常规治疗基础上联用托伐普坦片治疗心原性水肿的有效性和安全性的多中心随机、双盲、安慰剂对照研究[J].中华心力衰竭和心肌病杂志(中英文),2017,1(1):15-21. 被引量:26
  • 2兰亚明.糖尿病合并冠心病患者药物洗脱支架术后应用氯吡格雷的疗效[J].中国老年学杂志,2015,35(1):65-68. 被引量:23
  • 3中华医学会心血管病学分会,中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35:1076-1095.
  • 4Kiyosue A,Hirata Y,Ando J,et al.Plasma cystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney disease[J].Circ J,2010,74(11):2441-2447.
  • 5Dohi T,Miyauchi K,Okazaki S,et al.Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome[J].Atherosclerosis,2011,219(2):907-912.
  • 6Xu L,Zhou J,Huang S,Huang Y,et al.An association study between genetic polymorphisms related to lipoprotein-associatedphospholipase A(2)and coronary heart disease[J].Exp Ther Med,2013,5(3):742-750.
  • 7Apple FS,Smith SW,Pearce LA,et al.Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome[J].Clin Chem,2009,55(1):93-100.
  • 8Fay WP,Garg N,Sunkar M.Vascular functions of the plasminogen activation system[J].Arterioscler Thromb Vase Biol,2007,27(6):1231-1237.
  • 9Weyand CM,Goronzy JJ,Liuzzo G,et al.T-cell immunity in acute coronary syndromes[J].Mayo Clin Proc,2001,76(10):1011-1020.
  • 10Furenes EB,Seljeflot I,Solheim S,et al.Long-term influence of diet and/or omega-3 fatty acids on matrix metalloproteinase-9 and pregnancy-associated plasma protein-A in men at high risk of coronary heart disease[J].Scand J Clin Lab Invest,2008,68(3):177-184.

共引文献5451

同被引文献53

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部